Ranelic acid
| Code | Size | Price |
|---|
| TAR-T26041-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Ranelic acid is an organic acid capable of chelating metal cations. Strontium ranelate, the strontium salt of Ranelic acid, is utilized to treat osteoporosis and increase bone mineral density.
CAS:
135459-90-4
Formula:
C12H10N2O8S
Molecular Weight:
342.28
Purity:
0.98
SMILES:
OC(=O)CN(CC(O)=O)c1sc(C(O)=O)c(CC(O)=O)c1C#N
References
1. Wang Q, Li ZS, Sun BW. Methyl 5-[N,N-bis-(methoxy-carbonyl-meth-yl)amino]-4-cyano-2-methoxy-carbonyl-3-thio-phe ne-ethan-o-ate. Acta Crystallogr Sect E Struct Rep Online. 2008 Sep 13;64(Pt 10):o1927. doi: 10.1107/S1600536808028699. PubMed PMID: 21201135; PubMed Central PMCID: PMC2959377.
2. Deeks ED, Dhillon S. Strontium ranelate: a review of its use in the treatment of postmenopausal osteoporosis. Drugs. 2010 Apr 16;70(6):733-59. doi: 10.2165/10481900-000000000-00000. Review. PubMed PMID: 20394457.
3. Deeks ED, Dhillon S. Spotlight on strontium ranelate: in postmenopausal osteoporosis. Drugs Aging. 2010 Sep 1;27(9):771-3. doi: 10.2165/11206440-000000000-00000. Review. PubMed PMID: 20809666.
4. Bay?s M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2003 Sep;25(7):565-97. PubMed PMID: 14571286.